Diagnostic Criteria for ME/CFS - Committee Meeting 1
The first meeting of the Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome will be held on January 27-28, 2014, at the Keck Center, located at 500 5th Street NW, in Washington, DC. On January 27, there will be an afternoon-long session that is open to the public. Members of the public may participate in person or via webcast. Persons who plan on attending the meeting in person are requested to register in advance prior to January 22, 2013. Registration for persons attending the meeting in person will be open until seating capacity of the conference room is reached. All participants may participate via webcast. The webcast will be available on the meeting webpage on January 27, 2014. On January 28, the committee and staff will meet in closed session.
Written comments may be submitted to the committee at any time during our study process. There is no deadline or character limit to submit comments. As with any information sent to inform the committee, all written comments will be placed in a Public Access File in compliance with Section 15 of the Federal Advisory Committee Act.
If you would like to submit written comments for the first meeting, please use the email (firstname.lastname@example.org). Please focus your comments on the following question: "What is the most important aspect or information that this committee should consider throughout the course of the study?" Written comments received by January 22, 2014 will be distributed to the committee before the meeting on January 27. After January 27, written comments should be sent to the project email address (email@example.com). All comments will be considered by the committee, but they may be distributed after the meeting is adjourned.
In addition to accepting written comments from the public, the committee will have the opportunity to hear public comments from approximately 15 in-person attendees. Registration for these public comment spots is now full. If you were unable to register for a public comments spot during the open meeting, please consider sending your comments to the meeting email address (firstname.lastname@example.org).
Frequently Asked Questions:
What is the location and time of the open meeting?
The open meeting will be held on January 27, 2014 from 1:00 PM to 5:30 PM. It will be held in the Keck Center, Room 100. The address of the Keck Center is 500 5th Street NW, Washington, DC 20001.
How does the public check in for the meeting?
Visitors to the Keck Center must sign in with the security desk in the front lobby. Once you have signed in at the front door, you may proceed to the registration table outside of the entrance to the meeting room (Keck 100). It is recommended that attendees arrive 20 to 30 minutes early for the open session to facilitate the check-in process.
Is there a room where attendees can rest before or during the open meeting?
Keck 106 (located near the open meeting room) will be available for attendees.
Where are the restrooms located?
Restrooms and water fountains are located on the same floor as the open meeting, directly across from the meeting room.
What are the food and drink options available within the building and in the surrounding neighborhood?
The atrium cafeteria on the third floor is open from 7:00 AM until 2:30 PM. Choices available for purchase include a salad and sandwich bar as well as hot entrees, drinks, and snacks. In addition, there are food and drink vending machines located near the elevators on the third floor. The Keck Center is located in DC’s Penn Quarter neighborhood.
If I have any questions while in the building, who should I ask?
The security guards and program staff at the Keck Center are available to direct attendees upon request.
Who is able to participate via webcast?
The webcast will be open to all users.
Can the public submit comments during the open meeting?
Webcast attendees may also submit comments via the email (email@example.com). All written comments will be included in the Public Access File created for the study, and should not include any personal medical information.